Objective：To observe the clinical effect of modified Huaganjian combined with triple therapy for helicobacterpylori(Hp)positive chronic gastritis of stagnated heat in liver and stomach type.M e th o d s：Selected 80 cases of patients with Hp positive chronic gastritis of stagnated heat in liver and stomach type，and divided them into the control group and the experiment group randomly，40 cases in each group.The control group received triple therapy while the experiment group was given modified Huaganjian combined with triple therapy for treatment.Compared the clinical effect of the two groups，and observed the changes of pepsinogen I(PGⅠ)，PGⅡ and gastrin-17(G-17)in serum before and after treatment.R e s u lts：The total effective rate was 75.0%in the control group and was 90.0%in the experiment group，the difference being significant(P＜ 0.05).Before treatment，compared levels of G-17，PGⅠand PGⅡ in the two groups，there was no significance in the difference(P＜ 0.05).After treatment，levels of G-17，PGⅠand PGⅡin the two groups were decreased when compared with those before treatment，differences being significant(P＜0.05).Levels of G-17，PGⅠand PGⅡ in the experiment group were lower than those in the control group，differences being significant(P ＜ 0.05).Conclusion：The therapy of modified Huaganjian combined with triple therapy has significant curative effect in treating Hp positive chronic gastritis of stagnated heat in liver and stomach type，which can effectively reduce the gastric mucosal lesions of patients and enhance gastrointestinal function.